biospecimen__admin__batch_number	131.77.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	1B7D65FD-F35A-40B0-9935-62524D548C2E
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A1EJ-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A1EJ-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A1EJ-01A
biospecimen__bio__biospecimen_barcode_bottom	0099021434
biospecimen__bio__day_of_creation	31
biospecimen__bio__day_of_shipment	10
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	01
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-DD-A1EJ.A34C7F12-5EB1-4B7C-890C-FD2DFF41E85C.pdf
biospecimen__bio__plate_column	6
biospecimen__bio__plate_id	A155
biospecimen__bio__plate_row	D
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	4.54
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	26.70
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A1EJ
biospecimen__shared__patient_id	A1EJ
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-DD-A1EJ-A42216
clinical__ablation__bcr_ablation_uuid	CB81B953-600C-4EA2-A887-9AC76DF2AC04
clinical__ablation__days_to_embolization_performed	495
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Other
clinical__ablation__embolization_type	Radioembolization
clinical__ablation__embolizing_agent_utilized	Y-90 Therasphere
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	F42FB6C8-E119-4127-94C9-64E6B0C695A4
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.2
clinical__chol_lihc_shared__albumin_result_specified_value	3.5
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.7
clinical__chol_lihc_shared__child_pugh_classification_grade	B
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.1
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.6
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	18840
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.3
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	10.8
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	10.2
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	71
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A1EJ-F42209
clinical__clin_shared__bcr_followup_uuid	90900509-D9C8-46F1-ABC5-E5C6C01A03F8
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	15
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	2
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__measure_of_response	Clinical Progressive Disease
clinical__clin_shared__month_of_form_completion	4
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	608
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2008
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	263
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__rx__bcr_drug_barcode	TCGA-DD-A1EJ-D42213
clinical__rx__bcr_drug_uuid	432C8670-CC86-4488-92AC-E4C37DB72327
clinical__rx__days_to_drug_therapy_end	887
clinical__rx__days_to_drug_therapy_start	264
clinical__rx__drug_name	Sorafenib
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N1
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	c8b3eddd-f3cf-42eb-bb30-ccc3943eadec
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A1EJ-01A-11R-A155-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	f298fa39-2bc4-4589-bd90-48adde7a5f03,4de557ca-ac7b-403e-9ef5-3da663ed830a,b5c37657-cb0c-43bc-8f0c-ba6e785d8a5b
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - Counts,HTSeq - FPKM-UQ,HTSeq - FPKM
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.85
gdc__analytes__analyte_id	80ab7399-0e93-42bc-a801-ad764cad2f50
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	52292ffc-0902-4d97-b461-20723987a177
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-29T10:28:24.945429-05:00,2016-05-29T10:28:25.502649-05:00,2016-05-29T10:28:25.687027-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	40b9e642-18d5-5633-a7d9-9ccd013a24a2
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1937
gdc__diagnoses__age_at_diagnosis	26009
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-26009.0
gdc__diagnoses__days_to_death	1005.0
gdc__diagnoses__days_to_last_follow_up	887.0
gdc__diagnoses__diagnosis_id	6ae73e07-3dcb-56ad-ac46-3752cf20f759
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiic
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__bmi	26.986001011975038
gdc__exposures__exposure_id	8afca472-d9f6-52ef-84ba-6d15ff892c2e
gdc__exposures__height	154.0
gdc__exposures__weight	64.0
gdc__file_id	5f99719e-e0f0-41d9-b3bf-59b318030ffd,218860c9-51e3-43ae-a692-cb8165f6074b,e76ca5c6-11d1-47b8-bcdd-b5900dc1c55c
gdc__file_name	1a228668-b2a0-469f-8801-fdc8be449b44.htseq.counts.gz,1a228668-b2a0-469f-8801-fdc8be449b44.FPKM-UQ.txt.gz,1a228668-b2a0-469f-8801-fdc8be449b44.FPKM.txt.gz
gdc__file_size	252528,512682,511419
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	353189f900a2118eafd03692c2d5c2e0,4fcd466aa0492a4253c9eb04f9dcc045,6e0df52eb79c0d03d756aa5d9f5d660b
gdc__portions__is_ffpe	false
gdc__portions__portion_id	4ea36d6f-ece2-40e4-89ec-0b3fef9c83ee
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	909
gdc__samples__initial_weight	290.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	A34C7F12-5EB1-4B7C-890C-FD2DFF41E85C
gdc__samples__sample_id	2d549bb0-9e98-40c7-8b33-545c481dd105
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	5.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	15.0
gdc__slides__percent_tumor_cells	85.0
gdc__slides__percent_tumor_nuclei	85.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	5472bfa9-8d10-4d2c-8df5-e056acd74216
gdc__submitter_id	1a228668-b2a0-469f-8801-fdc8be449b44_count,1a228668-b2a0-469f-8801-fdc8be449b44_uqfpkm,1a228668-b2a0-469f-8801-fdc8be449b44_fpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	ba842480-3ef3-5544-b3f4-6dbda2c440ce
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:10:35.758+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/c8b3eddd-f3cf-42eb-bb30-ccc3943eadec-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/c8b3eddd-f3cf-42eb-bb30-ccc3943eadec-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5119312
manually_curated__local_md5	6f2c2bb12831f187fe73eeb0fd10bb73
manually_curated__opengdc_download_date	2018-10-15T16:22:54.000738+02:00
manually_curated__opengdc_file_md5	f9d17b955c41506459c693a17850b805
manually_curated__opengdc_file_size	1681975
manually_curated__opengdc_id	c8b3eddd-f3cf-42eb-bb30-ccc3943eadec-geq
manually_curated__origin_file_size	5119312
manually_curated__origin_last_modified_date	Mon Oct 15 16:34:00 CEST 2018
manually_curated__origin_md5	6f2c2bb12831f187fe73eeb0fd10bb73
manually_curated__tissue_status	tumoral
num	60483
